Changes to health technology evaluation

We've improved the way we evaluate medicines and other health technologies for use in the NHS.

Find out more

The changes we've made will help give patients earlier access to innovative new treatments.
Find out what's changed.

Evidence-based recommendations developed by independent committees, including professionals and lay members, and consulted on by stakeholders.

We want you to be involved in our work. There are many ways you can get involved as a healthcare professional or a member of the public.

Tell us what matters to you, your organisation or your community and we’ll share our latest news, features and guidance.

Find out more about

and how we support

The NICE strategy 2021 to 2026 sets out an ambitious vision for our future.

Over 500 people a year can access a new life extending lung cancer treatment after NICE recommends its use within the Cancer Drugs Fund

An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.
NICE draft guidance recommends tucatinib for advanced breast cancer

Taken as two 150 mg tablets twice daily together with anti-cancer medicines trastuzumab and capecitabine, tucatinib works by blocking a specific area of the HER2 gene in cancer cells, which stops the cells from growing and spreading.
Once-a-day capsule for people with some forms of ovarian, fallopian tube and peritoneal cancer recommended for routine use in the NHS

The 20th cancer treatment to go through the Cancer Drugs Fund following a period of managed access has been recommended for routine use in the NHS by NICE in final draft guidance published today (24 February).
NICE recommends new diagnostic devices for men with suspected prostate cancer in draft guidance

Four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related sepsis, have been recommended for use by NICE.

Into practice

Resources to help you use our guidance and quality standards
Financial planning

Advice and tools to help you make the best use of your resources
Antimicrobial resistance

View our antimicrobial prescribing guidelines
Our role in patient safety

Our guidelines make evidence-based, best practice recommendations.
Find journals and databases

Access to a range of journals and other evidence-based resources.